Dr. Joshua Larned, M.D.
What this data tells you about Dr. Larned
Dr. Joshua Larned is a cardiovascular disease in Fort Lauderdale, FL, with 18 years in practice. Based on federal Medicare data, Dr. Larned performed 4,451 Medicare services across 3,405 unique beneficiaries.
Between the years covered by Open Payments, Dr. Larned received a total of $35,954 from 21 pharmaceutical and/or device companies across 135 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Larned is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 1,492 | $75 | $329 |
| EKG interpretation and report | 1,152 | $6 | $30 |
| Echocardiogram, transthoracic | 389 | $52 | $477 |
| Hospital follow-up visit, high complexity | 268 | $94 | $378 |
| Initial hospital admission, high complexity | 174 | $138 | $674 |
| Office visit, established patient (20-29 min) | 141 | $51 | $223 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 133 | $14 | $190 |
| New patient office visit (45-59 min) | 132 | $104 | $454 |
| Remote pacemaker monitoring, 90 days | 70 | $23 | $106 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 67 | $16 | $73 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 67 | $11 | $49 |
| 3d radiographic procedure | 57 | $8 | $32 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 53 | $25 | $175 |
| Programming of dual lead pacemaker system | 50 | $27 | $268 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 40 | $58 | $1,549 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 28 | $20 | $88 |
| Ultrasound of both sides of head and neck blood flow | 24 | $28 | $647 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 23 | $28 | $189 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 22 | $52 | $628 |
| Critical care, first 30-74 min | 21 | $177 | $922 |
| Ultrasound of heart with probe in esophagus, with report | 13 | $85 | $352 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 13 | $2 | $40 |
| Programming of multiple lead implantable defibrillator system | 11 | $40 | $252 |
| Ultrasound of heart blood flow, valves and chambers | 11 | $14 | $109 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (90%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 10% for cardiovascular disease in FL.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Larned is a clinical cardiology specialist, with above-average Medicare volume (top 24% in FL), and high industry engagement (speaking/promotional, top 10%), with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Larned experienced with office visit, established patient (30-39 min)?
Does Dr. Larned receive payments from pharmaceutical companies?
How do Dr. Larned's costs compare to other cardiovascular diseases in Fort Lauderdale?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology